Results 41 to 50 of about 3,028,209 (373)
Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors [PDF]
, 2012 Background: Regulatory bodies including the European Medicines Agency register medications (formulation, route of administration) for specific clinical indications. Once registered, prescription is at clinicians’ discretion.
Abernethy, Amy Pickar +7 more
core +1 more source
Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital [PDF]
Farmacia Hospitalaria, 2015 Aim: To describe the off-label and unlicensed utilization patterns of drugs in a Brazilian pediatric hospital. Methods: The research consisted of a descriptive, prospective and cross-sectional study.
Vanessa Pereira Gomes +3 more
doaj +1 more source
Frontiers in Pharmacology, 2020 Dementia represents a global health challenge due to the increase in elderly population worldwide. In addition to memory loss, dementia often results in severe behavioral and psychological changes where pharmacological treatments might be considered in ...
Ismaeel Yunusa, Marie Line El Helou
semanticscholar +1 more source
Research and Reports in Tropical Medicine, 2020 COVID-19 is continuing as a big challenge for the globe and several types of research are continued to find safe and effective treatment and preventive options.
A. Belayneh
semanticscholar +1 more source
Evaluation of neuropsychiatric medicines off-label use applications
Psychiatry and Clinical Psychopharmacology, 2021 Objective: The term “Off-label use of medications (OLU)” covers the use of licensed medicines for non-listed indications and/or doses as well as the use of unlicensed medicinal products, which are imported for individual use. OLU is under the control of
Emine Nur Özdamar +5 more
doaj
JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2022 Off-label drug use is the prescription of drugs outside the indications approved by the authorized agency. The reasons for off-label drug use include a lack of clinical response to previous treatments, intolerance, or contraindications to drug therapy ...
Bangunawati Rahajeng +2 more
doaj +1 more source
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus [PDF]
, 2017 Patients with diabetes, especially pediatric ones, sometimes use continuous glucose monitoring (CGM) sensor in different positions from the approved ones. Here we compare the accuracy of Dexcom\uae G5 CGM sensor in three different sites: abdomen, gluteus
Claudio Cobelli +10 more
core +2 more sources
Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection
Journal of Medical Virology, 2020 The spread of the novel-Coronavirus infection worldwide represents a challenge for physicians. Particularly, no approved therapy has demonstrated to have an impact in treating patients who develop severe respiratory insufficiency so far.
S. Di Giambenedetto +10 more
semanticscholar +1 more source
Can registration procedures of pharmaceuticals inadvertently contribute to off-label prescribing in children? [PDF]
, 2016 Background: In Malta, off-label prescribing of medicines in children stands at 45%, mainly because of failure by prescribers to follow the dosing recommendations in the product literature.
Attard-Montalto, Simon +2 more
core +1 more source
American Journal of Tropical Medicine and Hygiene, 2020 . The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19).
Pascale M Abena +12 more
semanticscholar +1 more source